Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Introducing ICCON: A Global Initiative for Congenital Corneal Opacification

World Society of Paediatric Ophthalmology and Strabismus (WSPOS)
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 4th 2025

The International Congenital Corneal Opacification Network (ICCON) is a pioneering initiative dedicated to improving the care and management of children with congenital corneal opacities worldwide. Established by the World Society of Paediatric Ophthalmology and Strabismus (WSPOS) in collaboration with the Paediatric Keratoplasty Association (PKA), ICCON aims to connect specialists, surgeons, and healthcare professionals with a shared mission: ensuring that children with these rare yet challenging conditions receive the expertise and treatment they need.

The Birth of ICCON

ICCON was first conceptualised during a Focus Group Meeting at WCPOS V, 2024, where 50 experts from around the world participated both in-person and virtually. This discussion laid the foundation for a global network of ophthalmologists and surgeons who are willing to advise, manage, and operate on children with congenital corneal opacities.

Why ICCON Matters

Congenital corneal opacities present unique challenges, requiring highly specialised care. However, access to expertise varies significantly across regions. ICCON will act as a hub for collaboration, allowing specialists to exchange knowledge, guide treatment approaches, and ultimately enhance patient outcomes worldwide.

Join Us at the IX World Cornea Congress

To mark its official launch, ICCON will be introduced at the IX World Cornea Congress in Washington, DC. This milestone event will provide an opportunity for professionals in the field to learn more, get involved, and contribute to shaping the network’s future.

📅 Event Details:  IX World Cornea Congress

📍 Location: Meeting Room 15, Westin Washington, DC Downtown

🕠 Date & Time: Thursday, 20th March 2025 | 5:30 – 7:30 PM

💡 Entry is free, but pre-registration is required.

How to Get Involved

Attending in Person?
RSVP by emailing admin@wspos.org with the subject line:
📩“I’ll see you at the ICCON meeting in Washington, DC”
We’ll reserve your seat!

✅ Want to Be Part of ICCON Beyond the Meeting?
Even if you can’t attend in person, you can still be part of this growing global network. Register your interest to receive updates and opportunities to participate in ICCON’s future initiatives here: https://wspos.org/international-cco-network-form/

📌 Note: If you’re attending the event, you must also register to be involved in ICCON beyond the meeting.

📧 Questions? Contact us at admin@wspos.org or management@wspos.org.

Join us in building a worldwide network of expertise dedicated to advancing care for children with congenital corneal opacities. Your involvement can help shape the future of paediatric corneal surgery and management on a global scale.

Learn more: https://wspos.org/international-cco-network-form/


Register now to receive the touchOPHTHALMOLOGY newsletter!

Don’t miss out on hearing about our latest peer reviewed articles, expert opinions, conference news, podcasts and more.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup